Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
Françoise Dromer, Claire Bernede-Bauduin, Didier Guillemot et al. · 2008
Read Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis by Françoise Dromer, Claire Bernede-Bauduin, Didier Guillemot et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002870.txt.
Description
Françoise Dromer, Claire Bernede-Bauduin, Didier Guillemot and colleagues wrote a 2008 PLOS ONE study on severe cryptococcosis, a serious fungal infection. Guidelines from the year 2000 backed care with drugs such as amphotericin B, but those plans had not been fully tested across real clinical settings. The authors set out to check how well treatment choices held up in practice.
Much of the paper weighs the paired use of amphotericin B and flucytosine, named in the title as having a major role. It reviews cases where trial rules had left gaps in the evidence. For clinicians, the value is a closer look at drug choice for a hard and risky infection.
Catalog record
| CREATOR | Françoise Dromer, Claire Bernede-Bauduin, Didier Guillemot et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002870